Clarithromycin Tablet
Product Images NDC 82804-069

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 82804-069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-069-20 (500mg60)

82804-069-20 (500mg60)
Label for Clarithromycin 500 mg tablets by Proficient Rx LP, with a package count of 20 tablets. The label indicates each tablet contains 500 mg of clarithromycin and describes the tablets as white, oval-shaped, film-coated, debossed with 'GG C9' on one side and plain on the reverse. The product ID is ZC006920, manufactured by S.C. Sandoz S.R.L. in Romania, product of China. Storage instructions and multiple identifiers including NDC 82804-069-20 are also present.*
FDA Label Image

Clarithrofigure2 (Clarithromycinfigure2)

Clarithrofigure2 (Clarithromycinfigure2)
A line graph comparing mean plasma concentration (mcg/mL) of clarithromycin over 24 hours after dosing. It contrasts extended-release clarithromycin (2 x 500 mg every 24 hours) with standard 500 mg dosing every 12 hours, showing concentration trends across time intervals from 0 to 24 hours post-dose.*
FDA Label Image

Chemicalstructure (Clarithromycin)

Chemicalstructure (Clarithromycin)
Chemical structure diagram of clarithromycin, showing its molecular components and bonds.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A survival curve chart comparing the proportion surviving over days since randomization between Clarithromycin and placebo. The chart shows two lines: a solid line for Clarithromycin and a dotted line for placebo, with survival proportions decreasing over time, and the Clarithromycin line consistently above the placebo line throughout approximately 700 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.